Concepedia

Author

Tomonori Senoh

Kagawa Prefectural Central Hospital

Also Known As

T Senoh, T. Senoh, TOMONORI SENOH, Tomonori SENOH, Tomonori Senoh

57

Publications

763

Citations

18

H-Index

36

Concepts

All Affiliations

Kagawa Prefectural Central HospitalOgaki Municipal HospitalEhime Prefectural Central HospitalShinmatsudo Central General HospitalOkayama University
TS

About

Tomonori Senoh is an author at Kagawa Prefectural Central Hospital specializing in medicine, viral hepatitis, and hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

291

2

Hepatology

7

7

225

3

Health Sciences

3

3

143

4

Epidemiology

3

3

96

5

Cell Biology

1

1

23

Tomonori Senoh

×

25

Publications

666

Citations

18

H-Index

YearCitations

Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy

Yoshiaki Iwasaki, Kouichi Takaguchi, Hiroshi Ikeda,

Liver International

2004

68

Lamivudine treatment in patients with HBV-related hepatocellular carcinoma--using an untreated, matched control cohort.

Cheng Yu Piao, Shin Fujioka, Yoshiaki Iwasaki,

PubMed

2005

65

Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct‑acting antiviral treatment: All Kagawa Liver Disease Group Study

Joji Tani, Asahiro Morishita, Teppei Sakamoto,

Oncology Letters

2020

55

Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B

Hidenori Toyoda, Takashi Kumada, Toshifumi Tada,

Journal of Hepatology

2016

43

Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy

Etsuko Iio, Noritomo Shimada, Koichi Takaguchi,

Hepatology Research

2017

37

TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy

Etsuko Iio, Kentaro Matsuura, Noritomo Shimada,

Journal of Gastroenterology

2018

32

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon‐free versus interferon‐based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan

Hidenori Toyoda, Toshifumi Tada, Koichi Takaguchi,

Journal of Viral Hepatitis

2016

31

Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study

Chikara Ogawa, Masahiro Morita, Akina Omura,

Oncology

2017

29

Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan

Hidenori Toyoda, Masanori Atsukawa, Koichi Takaguchi,

Journal of Gastroenterology

2018

29

Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan

Hidenori Toyoda, Masanori Atsukawa, Haruki Uojima,

Open Forum Infectious Diseases

2019

26

Page 1